InsiderTrades.com logo
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Get Your Free Gold Guide

FDMT Insider Trading

Insider Ownership Percentage: 7.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $16,382,869.22

4D Molecular Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at 4D Molecular Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

4D Molecular Therapeutics Share Price & Price History

Current Price: $8.41
Price Change: ▼ Price Decrease of -0.26 (-3.00%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for FDMT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
From Darwin   |   Ad
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!

4D Molecular Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2024Scott BizilyInsiderSell500$16.33$8,165.006,781View SEC Filing Icon  
7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.506,781View SEC Filing Icon  
7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.006,781View SEC Filing Icon  
7/10/2024David KirnCEOSell12,923$22.49$290,638.271,059,153View SEC Filing Icon  
7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.281,737View SEC Filing Icon  
6/24/2024David KirnCEOSell12,930$23.10$298,683.001,059,153View SEC Filing Icon  
5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.501,737View SEC Filing Icon  
4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.001,737View SEC Filing Icon  
4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.341,737View SEC Filing Icon  
3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.321,737View SEC Filing Icon  
3/18/2024Scott BizilyInsiderSell1,750$31.27$54,722.501,737View SEC Filing Icon  
2/27/2024Scott BizilyInsiderSell1,909$30.00$57,270.001,737View SEC Filing Icon  
2/16/2024Scott BizilyInsiderSell1,750$27.67$48,422.501,737View SEC Filing Icon  
2/8/2024David KirnCEOSell92,001$27.13$2,495,987.131,059,153View SEC Filing Icon  
2/8/2024Scott BizilyInsiderSell6,244$27.50$171,710.001,737View SEC Filing Icon  
2/5/2024Robert Young KimInsiderSell24,552$30.05$737,787.601,043View SEC Filing Icon  
1/23/2024David KirnCEOSell5,696$18.41$104,863.361,151,154View SEC Filing Icon  
1/4/2024David KirnCEOSell40,732$20.31$827,266.921,185,087View SEC Filing Icon  
1/4/2024Global Investors Lp VikingMajor ShareholderSell540,000$19.53$10,546,200.004,247,914View SEC Filing Icon  
6/8/2023Scott BizilyInsiderSell3,750$20.85$78,187.501,737View SEC Filing Icon  
6/1/2023Scott BizilyInsiderSell2,247$18.31$41,142.571,737View SEC Filing Icon  
5/9/2023Global Investors Lp VikingMajor ShareholderBuy850,000$16.00$13,600,000.004,787,914View SEC Filing Icon  
4/21/2023Jacob ChackoDirectorSell5,000$20.05$100,250.00View SEC Filing Icon  
4/21/2023Scott BizilyInsiderSell3,750$20.00$75,000.002,109View SEC Filing Icon  
3/1/2023Scott BizilyInsiderSell2,248$19.30$43,386.402,109View SEC Filing Icon  
2/21/2023David KirnCEOSell17,997$20.96$377,217.121,875,602View SEC Filing Icon  
1/19/2023David KirnCEOSell10,899$20.03$218,306.971,902,224View SEC Filing Icon  
12/15/2022David KirnCEOSell32,933$23.59$776,889.471,967,067View SEC Filing Icon  
12/1/2022Scott BizilyInsiderSell6,000$22.79$136,740.002,482View SEC Filing Icon  
See Full Table
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide

SEC Filings (Institutional Ownership Changes) for 4D Molecular Therapeutics (NASDAQ:FDMT)

99.27% of 4D Molecular Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FDMT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

4D Molecular Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC114,848$1.24M0.0%+141.0%0.248%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,036,545$11.21M0.0%-2.3%1.995%Search for SEC Filing on Google Icon
11/15/2024M&T Bank Corp18,848$0.20M0.0%-35.0%0.036%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC114,848$1.24M0.0%+141.0%0.221%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd24,538$0.27M0.0%+81.3%0.047%Search for SEC Filing on Google Icon
11/15/2024National Bank of Canada FI71,000$0.77M0.0%-41.3%0.137%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP166,190$1.80M0.0%-7.4%0.320%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.48,702$0.53M0.1%-79.9%0.094%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,116,508$22.88M0.0%+1.8%4.073%Search for SEC Filing on Google Icon
11/15/2024Redmile Group LLC1,262,090$13.64M0.8%+17.6%2.428%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.15,341$0.17M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC3,137,087$33.92M0.0%-1.9%6.036%Search for SEC Filing on Google Icon
11/15/2024ArrowMark Colorado Holdings LLC803,490$8.69M0.1%-5.5%1.546%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP1,225,448$13.25M0.4%+231.7%2.358%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC422,856$4.57M0.1%-52.0%0.814%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC84,322$0.91M0.0%N/A0.162%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC41,399$0.45M0.0%-13.1%0.080%Search for SEC Filing on Google Icon
11/14/2024Healthcare of Ontario Pension Plan Trust Fund459,000$4.96M0.0%-35.0%0.883%Search for SEC Filing on Google Icon
11/13/2024FMR LLC4,100$44K0.0%-99.6%0.008%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC73,436$0.79M0.0%+342.7%0.141%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC24,761$0.27M0.0%N/A0.048%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.27,323$0.30M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP37,662$0.41M0.0%-42.0%0.072%Search for SEC Filing on Google Icon
11/2/2024Privium Fund Management B.V.98,500$1.07M0.3%+146.3%0.190%Search for SEC Filing on Google Icon
11/1/2024Proficio Capital Partners LLC10,000$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.9,995$0.11M0.0%+64.6%0.019%Search for SEC Filing on Google Icon
10/24/2024Nisa Investment Advisors LLC44,769$0.48M0.0%-53.7%0.087%Search for SEC Filing on Google Icon
10/24/2024Novo Holdings A S1,500,000$16.22M0.8%+7.1%2.901%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.5,315$57K0.0%N/A0.010%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.1,543,414$16.68M0.0%+238.3%2.985%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC3,700$40K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC29,710$0.32M0.0%N/A0.057%Search for SEC Filing on Google Icon
9/20/2024Healthcare of Ontario Pension Plan Trust Fund706,000$14.82M0.0%+10.1%1.365%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC16,588$0.35M0.0%+20.6%0.032%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company18,975$0.40M0.0%+25.5%0.037%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC110,041$2.31M0.0%+652.7%0.213%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP185,866$3.90M0.0%-27.9%0.359%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC17,962$0.38M0.0%-26.5%0.035%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC11,910$0.25M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.271,155$5.69M0.3%+36.8%0.524%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP532,742$11.18M0.0%-28.9%1.030%Search for SEC Filing on Google Icon
8/8/2024Parallel Advisors LLC19,778$0.42M0.0%+59,833.3%0.038%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.12,787$0.27M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC5,778$0.12M0.0%+17,409.1%0.011%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers72,933$1.53M0.0%+14.2%0.141%Search for SEC Filing on Google Icon
8/1/2024Privium Fund Management B.V.40,000$0.82M0.2%+29.0%0.077%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.21,034$0.44M0.0%+9.6%0.041%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.354,857$7.45M0.0%+247.7%0.686%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp169,413$3.56M0.0%+28.9%0.328%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC96,698$2.03M0.0%+5,735.7%0.187%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.456,267$9.58M0.0%+6.0%0.883%Search for SEC Filing on Google Icon
6/4/2024DekaBank Deutsche Girozentrale30,000$0.96M0.0%-34.8%0.058%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.344,123$10.96M2.4%+11.5%0.666%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.5,051,511$160.94M2.0%+21.3%9.771%Search for SEC Filing on Google Icon
5/17/2024Zimmer Partners LP138,800$4.42M0.1%N/A0.268%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System28,490$0.91M0.0%+12.6%0.055%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC3,197,444$101.84M0.1%+3.4%6.185%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC136,771$4.36M0.1%N/A0.265%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL3,922,413$124.97M3.4%-2.1%7.587%Search for SEC Filing on Google Icon
5/16/2024Redmile Group LLC1,261,427$40.19M1.5%N/A2.440%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP100,000$3.19M0.0%N/A0.193%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG15,700$0.50M0.0%N/A0.030%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD23,952$0.76M0.0%+6.0%0.046%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC1,533$48K0.0%-83.9%0.003%Search for SEC Filing on Google Icon
5/14/2024Decheng Capital LLC347,835$11.08M1.5%N/A0.673%Search for SEC Filing on Google Icon
5/14/2024Platinum Investment Management Ltd.40,767$1.30M0.1%N/A0.079%Search for SEC Filing on Google Icon
5/14/2024Healthcare of Ontario Pension Plan Trust Fund641,000$20.42M0.1%+1,076.1%1.240%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,339,943$74.55M0.0%+25.3%4.574%Search for SEC Filing on Google Icon
5/9/2024Mitsubishi UFJ Asset Management Co. Ltd.18,967$0.60M0.0%-4.4%0.037%Search for SEC Filing on Google Icon
5/8/2024Entropy Technologies LP7,487$0.24M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC10,788$0.34M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.15,818$0.50M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/7/2024Concurrent Investment Advisors LLC17,325$0.55M0.0%N/A0.034%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank53,900$1.72M0.0%+29.9%0.105%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC4,583$0.15M0.0%-83.0%0.009%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.20,098$0.64M0.0%-7.0%0.039%Search for SEC Filing on Google Icon
4/30/2024Privium Fund Management B.V.31,000$0.99M0.3%-8.0%0.061%Search for SEC Filing on Google Icon
4/30/2024Perigon Wealth Management LLC146,150$4.66M0.1%-40.6%0.286%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC3,457$0.11M0.0%+702.1%0.007%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.19,185$0.61M0.0%+92.2%0.038%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.9,579$0.31M0.0%+93.5%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.430,556$13.72M0.0%N/A0.842%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC3,457$0.11M0.0%+702.1%0.007%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP180,475$3.66M0.0%+4.5%0.363%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.816,343$16.54M0.0%+415.8%1.910%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.142,510$2.89M1.2%N/A0.333%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC126,589$2.57M0.0%-21.5%0.296%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.52,564$1.07M0.0%+266.0%0.123%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.103,671$2.10M0.0%+37.0%0.243%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.19,835$0.40M0.0%+29.8%0.046%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.268,638$5.44M0.0%+3.9%0.628%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank41,500$0.84M0.0%-10.0%0.097%Search for SEC Filing on Google Icon
2/2/2024Bfsg LLC1,500$30K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund19,422$0.39M0.0%+40.6%0.045%Search for SEC Filing on Google Icon
1/31/2024Daiwa Securities Group Inc.5,872$0.12M0.0%+23.3%0.014%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank5,571$0.11M0.0%-17.7%0.013%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.142,510$2.89M0.0%N/A0.333%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.21,612$0.44M0.0%+14.3%0.051%Search for SEC Filing on Google Icon
1/24/2024DekaBank Deutsche Girozentrale46,000$0.97M0.0%N/A0.108%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,951$100K0.0%+359.3%0.012%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
4D Molecular Therapeutics logo
4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States. The company develops a portfolio of genetic medicine product candidates focuses in three therapeutic areas for ophthalmology, cardiology, and pulmonology. Its product pipeline includes 4D-150, which is in phase 1/2 clinical trial for the treatment of wet age-related macular degeneration; and is in phase 1/2 clinical trial for the treatment of diabetic macular edema. The company develops 4D-125, which is in phase 1/2 clinical trial for the treatment of x-linked retinitis pigmentosa; 4D-110, which is in phase 1/2 clinical trial for the treatment of choroideremia; 4D-710, which is in phase 1/2 clinical trial for the treatment cystic fibrosis lung disease; and 4D-310 to treat fabry disease cardiomyopathy and is in phase 1/2 clinical trial. In addition, its product candidates comprises 4D-175, which is in pre-clinical development for the treatment for geographic trophy; and 4D-725 to treat alpha-1 antitrypsin deficiency lung disease and is in pre-clinical development. The company has collaboration and licensing agreements with Arbor Biotechnologies, Inc.; Astellas Gene Therapies, Inc; uniQure biopharma B.V.; and Cystic Fibrosis Foundation. 4D Molecular Therapeutics, Inc. was founded in 2013 and is headquartered in Emeryville, California.
Read More on 4D Molecular Therapeutics

Today's Range

Now: $8.41
Low: $8.20
High: $8.96

50 Day Range

MA: $9.88
Low: $7.71
High: $16.82

52 Week Range

Now: $8.41
Low: $7.32
High: $36.25

Volume

652,199 shs

Average Volume

896,582 shs

Market Capitalization

$388.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.82

Who are the company insiders with the largest holdings of 4D Molecular Therapeutics?

4D Molecular Therapeutics' top insider shareholders include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. David Kirn (CEO)
  3. Scott Bizily (Insider)
  4. Robert Young Kim (Insider)
  5. Jacob Chacko (Director)
Learn More about top insider investors at 4D Molecular Therapeutics.

Who are the major institutional investors of 4D Molecular Therapeutics?

4D Molecular Therapeutics' top institutional shareholders include:
  1. Janus Henderson Group PLC — 6.04%
  2. State Street Corp — 4.07%
  3. Assenagon Asset Management S.A. — 2.99%
  4. Novo Holdings A S — 2.90%
  5. Redmile Group LLC — 2.43%
  6. Braidwell LP — 2.36%
Learn More about top institutional investors of 4D Molecular Therapeutics stock.

Which institutional investors are selling 4D Molecular Therapeutics stock?

During the previous quarter, FDMT stock was sold by these institutional investors:
  1. FMR LLC
  2. Eventide Asset Management LLC
  3. Healthcare of Ontario Pension Plan Trust Fund
  4. Sphera Funds Management LTD.
  5. Janus Henderson Group PLC
  6. Nisa Investment Advisors LLC
  7. National Bank of Canada FI
  8. ArrowMark Colorado Holdings LLC
During the previous year, company insiders that have sold 4D Molecular Therapeutics company stock include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. David Kirn (CEO)
  3. Scott Bizily (Insider)
  4. Robert Young Kim (Insider)
Learn More investors selling 4D Molecular Therapeutics stock.

Which institutional investors are buying 4D Molecular Therapeutics stock?

Within the last quarter, FDMT stock was bought by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Braidwell LP
  3. Redmile Group LLC
  4. Novo Holdings A S
  5. Walleye Capital LLC
  6. Barclays PLC
  7. Barclays PLC
  8. Privium Fund Management B.V.
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Get Your Free Gold Guide